STOCK TITAN

CANBD - $CANBD STOCK NEWS

Welcome to our dedicated page for CANBD news (Ticker: $CANBD), a resource for investors and traders seeking the latest updates and insights on CANBD stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANBD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANBD's position in the market.

Rhea-AI Summary
Can B Corp. secures ownership of two cannabis patents valued at $122 million, potentially up to $750 million, extending to 2035. The patents cover cannabis extracts, liquid formulations, and methods of managing various conditions. Can B plans to monetize these patents in a growing industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Can B Corp. announces consolidation of Pure Health Product operations, saving nearly $500,000 annually. Colorado is now the base of operations for all manufacturing and shipping.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
-
Rhea-AI Summary
Can B Corp. has announced a newly awarded contract with One Bad Moon Rising and the purchase of 1.8 million pounds of biomass. The biomass is stored in Ft. Morgan, Colorado and is ready for immediate processing. The purchase price of the biomass was $2.7 million, paid with Rule 144 restricted stock. Can B's CEO is excited about the new opportunity and looks forward to utilizing their fully integrated operations to produce isomers. One Bad Moon Rising is impressed with Can B's facilities and is excited to fulfill the demand for isomers with their new contract.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.89%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-31.43%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
CANBD

OTC:CANBD

CANBD Rankings

CANBD Stock Data

11.78M
1.72M
10.64%
0.37%
Drug Manufacturers—Specialty & Generic
Healthcare
Link
United States
Hicksville